Medincell at Piper Sandler CNS Symposium 2026

Medincell (Euronext: MEDCL) announced that Dr. Grace Kim, the company's Chief Strategy Officer, will participate in the Piper Sandler CNS Symposium on August 13, 2026. The event will be held virtually at 6:30 p.m. Paris time. Dr. Kim will engage with investors in a fireside chat moderated by Piper Sandler analysts. Investors will also have the opportunity to schedule one-on-one meetings with Medincell.

Based in Montpellier, Medincell distinguishes itself in the development and marketing of long-acting injectable treatments. Their BEPO technology ensures adherence to prescribed medications and improves accessibility. Risperidone LAI, which utilizes this technology, has received FDA approval for conditions such as schizophrenia and bipolar disorder.